NI Pharmacist Struck Off After 25,000 Diazepam Tablets Went Missing Over Three Years

Date of Decision: April 16, 2026

Registrant's Role: Pharmacist

Allegations:

  • Conviction for unlawful possession of a Class C controlled drug, namely diazepam, between 1 January 2021 and 21 March 2024.
  • Conviction for theft of diazepam tablets belonging to the pharmacy employer during the same period.
  • Unlawfully obtaining diazepam for the registrant’s own use or another’s use without a valid prescription, without making a supply record, and where the supply was not clinically appropriate.
  • Abusing the position of pharmacist and pharmacy practice manager to obtain diazepam, a prescription only medicine and Class C controlled drug, unlawfully.
  • Failing, while acting as Responsible Pharmacist, to ensure the safe and effective supply of diazepam from retail pharmacy premises.
  • Unlawfully obtaining diazepam from the pharmacy with intent to sell, supply, distribute, or divert it for use by others.
  • Obtaining diazepam in such quantities and circumstances that it could not credibly have been only for personal use, and causing, allowing, or permitting its sale, supply, distribution, or diversion to others.

Outcome: Removal of the registrant’s name from the register. An interim suspension was also imposed for the 28-day appeal period, or until any appeal is finally disposed of.

GPhC Standards Breached:

  • Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
  • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
  • Standard 2.1.6 – Ensure that you do not, whether by your actions or omissions, create a risk to patient care or public safety.
  • Standard 2.1.11 – Avoid treating yourself or anyone with whom you have a close personal relationship except for minor ailments or in an emergency.
  • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practice.
  • Standard 2.3.1 – Complete records promptly or as soon as reasonably practicable after the patient intervention or activity has occurred.
  • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside your work environment.
  • Standard 3.1.2 – Maintain public trust and confidence in your profession by acting with honesty and integrity in your dealings with others. This applies to your professional, business and educational activities.
  • Standard 3.1.6 – Promptly inform the regulator, your employer and other relevant authorities of any circumstances that may call into question your fitness to practise or has the potential to bring the profession of pharmacy into disrepute.

Case Summary

Allegations

This case concerned a pharmacist who, over a prolonged period from 1 January 2021 to 21 March 2024, unlawfully obtained diazepam from the community pharmacy where the registrant worked as both pharmacist and pharmacy practice manager. The registrant also routinely acted as the Responsible Pharmacist for the premises. The case arose after anomalies were detected through controlled drug reconciliation data relating to diazepam 5 mg tablets. Medicines Regulatory Group officers inspected the pharmacy and later seized pharmacy records. Their reconciliation of purchasing and lawful supply records found that 25,086 diazepam 5 mg tablets were unaccounted for over roughly three years. The regulator’s case was that these tablets had been ordered into the pharmacy, were no longer present on the premises, and had not been lawfully dispensed on NHS or private prescription.

For a pharmacist audience, the medication at the centre of this case is especially significant. Diazepam is both a Prescription Only Medicine and a Class C controlled drug. It is also specifically recognised in the determination as a substance liable to misuse and abuse. That matters because controlled drugs require robust governance at every stage: procurement, storage, record-keeping, clinical authorisation, and supply. The allegations were not limited to poor paperwork or an isolated stock discrepancy. They concerned repeated unlawful supply without a prescription, absent patient medication records, non-clinically appropriate access to a controlled drug, and diversion on a scale that raised concern not only about self-use but also about supply to others.

Continue Reading the Full Case

Create a free account or log in to access the complete case summary.

  • Full allegations considered by the GPhC
  • Panel findings and reasoning
  • Outcome of the investigation
  • Sanctions considered and imposed on the Pharmacist
  • Key professional learning points

Register for Free or Log In

Original Case Document

View the Full Determination Document

The original determination transcript is available to registered users.

  • Download the official GPhC determination
  • Full hearing transcript
  • Detailed findings of fact
  • Sanction reasoning
  • Details of the pharmacy professionals involved

Register for Free or Log In

Leave a Reply